Endologix, Inc. Gains 34.35%
Mon, Feb 24, 2020 at 05:30 PM
Endologix, Inc. (ELGX:NASDAQ) jumped higher at $1.11, representing a gain of 34.4%. On Fri 21 Feb 20, ELGX:NASDAQ hit a New 2-Week Low of $0.83. The stock got featured on our News Catalysts scanner on Thu 20 Feb 20 at 05:25 PM in the 'BIOTECH' category. From Fri 31 Jan 20, the stock recorded 21.43% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Endologix, Inc. (ELGX:NASDAQ)
Endologix Inc develops, manufactures, markets and sells medical devices for the treatment of aortic disorders. Its products are intended for the treatment of abdominal aortic aneurysms.
Top 10 Gainers:
- Lipocine Inc. (LPCN:NASDAQ), 67.39%
- Correvio Pharma Corp. (CORV:NASDAQ), 61.12%
- NanoViricides, Inc. (NNVC:NYSEMKT), 38.37%
- VelocityShares Daily 2x VIX Short-Term ETN (TVIX:NASDAQ), 37.05%
- Ambow Education Holding Ltd. (AMBO:NYSEMKT), 34.91%
- Endologix, Inc. (ELGX:NASDAQ), 34.35%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.85%
- NYSE Tick Pilot Test Sym-Contro (NTEST:NYSE), 27.92%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 27.24%
- Document Security Systems, Inc. (DSS:NYSEMKT), 26.33%